Azelaic Acid Acne Update 2026: Evidence and Open Questions

Azelaic acid still holds a conditional spot for acne care in 2026, backed by moderate-certainty trials but with open questions. It is a topical dicarboxylic acid that lowers Cutibacterium acnes, normalizes follicular keratinization, calms inflammation, and limits pigment after breakouts.

In the United States, prescription 20% cream holds FDA approval for acne vulgaris. The 15% gel and foam hold approval for rosacea, according to the Skin Therapy Letter topical treatments update. Typical use is a thin film applied twice daily.

Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.

What does it do in skin?
How strong is trial support?
Who may benefit most?
How do you fit it into a routine?
What questions remain for 2026?

What does it do in skin?

According to the Practical Dermatology review, azelaic acid acts in four ways. It is antibacterial against Cutibacterium acnes and normalizes follicular keratinization. That dual action targets clogged pores and bacterial growth.

It also calms inflammation and inhibits tyrosinase. Tyrosinase is the enzyme that drives melanin formation. Less enzyme activity means lighter healing marks after breakouts.

How strong is trial support?

The 2023 Journal of Cosmetic Dermatology systematic review found azelaic acid superior to vehicle for lesion counts and global improvement systematic review summary. That means more clearing than an inactive base. Benefit covered both severity reduction and overall appearance.

The May 2020 Cochrane review tested tougher head-to-head comparisons full Cochrane review. It found participant-reported improvement probably worse than benzoyl peroxide. It found probably little to no difference versus tretinoin and possibly little to no difference versus clindamycin.

Who may benefit most?

The 2024 American Academy of Dermatology guidelines give a conditional recommendation based on three randomized trials with moderate-certainty evidence, as reported in MdEdge coverage inside the 2024 AAD acne guidelines. Conditional means benefits likely outweigh harms for many people. The guidelines note particular value for sensitive skin and darker skin types because of its lightening effect.

A 16-week baseline-controlled study of 15% gel twice daily reduced mild-to-moderate acne and moderate-to-severe post-inflammatory hyperpigmentation, according to the PubMed/Kircik 2011 abstract. That pairing suits readers whose breakouts clear but leave brown marks. Darker skin types prone to these marks gain direct relevance.

How do you fit it into a routine?

Apply a thin film to affected areas twice daily. Keep the rest of the routine simple so you can judge response. Add moisturizer as needed for dryness or mild irritation.

A comparative study review citing Gollnick trials describes only mild transient effects with no systemic effects. The same review notes it is considered safe for acne treatment during pregnancy and lactation, unlike topical retinoids. Ask your clinician if it fits when retinoids are off the table.

use a thin film over acne-prone areas, not a thick layer
expect mild transient burning, stinging, or redness at first
keep use steady for weeks before judging clearing and fading

What questions remain for 2026?

Evidence versus adapalene remains very low certainty, according to Cochrane 2020. Long-term maintenance use is not yet defined. Combination roles with retinoids, benzoyl peroxide, or clindamycin also need clearer testing.

Optimal choice between 10% cosmetic products and 15-20% prescription formulas needs more randomized trials, per AAD 2024 limitation statements. Prescription strengths carry the current trial support for acne. If dark marks dominate, ask a dermatologist whether twice-daily 15% gel fits your plan.